MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sah, D. W.
Right arrow Articles by Bean, B. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sah, D. W.
Right arrow Articles by Bean, B. P.

Inhibition of P-type and N-type calcium channels by dopamine receptor antagonists

DW Sah and BP Bean

Department of Neurobiology, Harvard Medical School, Boston, Massachusetts 02115.

P-type Ca2+ channels in cerebellar Purkinje neurons and N-type Ca2+ channels in sympathetic neurons were found to be inhibited by D2 dopamine receptor antagonists with diverse structures, including phenothiazines (chlorpromazine and thioridazine), diphenylbutylpiperidines (fluspirilene and pimozide), butyrophenones (haloperidol and spiperone), and a piperazine (fluphenazine). Dopamine and quinpirole had no effect on P-type Ca2+ channels. In all cases, inhibition was characterized by slow onset and offset. The effects of P- type and N-type channels were very similar. Fluspirilene was the most potent of the drugs, with EC50 values of 6 microM for P-type current and 2 microM for N-type current. Block of P-type channels by fluspirilene was voltage dependent, being enhanced by depolarized holding potentials, and use dependent, being enhanced by higher stimulation frequencies. The effect of fluspirilene on the P-type Ca2+ channel current was not prevented by simultaneous exposure to the peptide toxin omega-agatoxin IVA, indicating that fluspirilene binds to a distinct site on the channel. The results suggest that N-type and P- type Ca2+ channels possess similar binding sites for dopamine receptor antagonists and that block of N-type and P-type channels is relatively weak, compared with that of some T-type and L-type Ca2+ channels.

Volume 45, Issue 1, pp. 84-92, 01/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Hill and M. Schaefer
TRPA1 Is Differentially Modulated by the Amphipathic Molecules Trinitrophenol and Chlorpromazine
J. Biol. Chem., March 9, 2007; 282(10): 7145 - 7153.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. T. Gulledge and G. J. Stuart
Action Potential Initiation and Propagation in Layer 5 Pyramidal Neurons of the Rat Prefrontal Cortex: Absence of Dopamine Modulation
J. Neurosci., December 10, 2003; 23(36): 11363 - 11372.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. Day, P. A. Olson, J. Platzer, J. Striessnig, and D. J. Surmeier
Stimulation of 5-HT2 Receptors in Prefrontal Pyramidal Neurons Inhibits Cav1.2 L-Type Ca2+ Currents Via a PLCbeta /IP3/Calcineurin Signaling Cascade
J Neurophysiol, May 1, 2002; 87(5): 2490 - 2504.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
S. I. McDonough, L. M. Boland, I. M. Mintz, and B. P. Bean
Interactions among Toxins That Inhibit N-type and P-type Calcium Channels
J. Gen. Physiol., March 12, 2002; 119(4): 313 - 328.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. M. Santi, F. S. Cayabyab, K. G. Sutton, J. E. McRory, J. Mezeyova, K. S. Hamming, D. Parker, A. Stea, and T. P. Snutch
Differential Inhibition of T-Type Calcium Channels by Neuroleptics
J. Neurosci., January 15, 2002; 22(2): 396 - 403.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Marrannes and E. De Prins
Site of Action of Lubeluzole on Voltage-Sensitive Ca2+ Channels in Isolated Dorsal Root Ganglion Cells of the Rat: Influence of pH
J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 531 - 545.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
M. C. H. Holland, S. Hassin, and Y. Zohar
Effects of Long-Term Testosterone, Gonadotropin-Releasing Hormone Agonist, and Pimozide Treatments on Gonadotropin II Levels and Ovarian Development in Juvenile Female Striped Bass (Morone saxatilis)
Biol Reprod, November 1, 1998; 59(5): 1153 - 1162.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics